These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9522840)

  • 21. [New therapeutic options in Alzheimer's disease].
    García-Ruiz Espiga PJ; Echeverría A; García-Torres A; Contreras A
    Rev Neurol; 2006 Apr 16-30; 42(8):478-81. PubMed ID: 16625510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination therapy for early Alzheimer's disease: what are we waiting for?
    Doraiswamy PM; Steffens DC
    J Am Geriatr Soc; 1998 Oct; 46(10):1322-4. PubMed ID: 9777922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What's new in Alzheimer's disease?
    Long CO; Dougherty J
    Home Healthc Nurse; 2003 Jan; 21(1):8-14; quiz 15. PubMed ID: 12544456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Empirical evidence of neuroprotection by dual cholinesterase inhibition in Alzheimer's disease.
    Venneri A; McGeown WJ; Shanks MF
    Neuroreport; 2005 Feb; 16(2):107-10. PubMed ID: 15671856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuation of functional hyperemia to visual stimulation in mild Alzheimer's disease and its sensitivity to cholinesterase inhibition.
    Janik R; Thomason LA; Chaudhary S; Dorr A; Scouten A; Schwindt G; Masellis M; Stanisz GJ; Black SE; Stefanovic B
    Biochim Biophys Acta; 2016 May; 1862(5):957-65. PubMed ID: 26521151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination therapy in Alzheimer's disease: a review of current evidence.
    Schmitt B; Bernhardt T; Moeller HJ; Heuser I; Frölich L
    CNS Drugs; 2004; 18(13):827-44. PubMed ID: 15521788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Strategies for the treatment of Alzheimer's disease. The 'ad continuum' concept].
    Boada Rovira M
    Rev Neurol; 2001 Jun 1-15; 32(11):1074-84. PubMed ID: 11562834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multifunctional scutellarin-rivastigmine hybrids with cholinergic, antioxidant, biometal chelating and neuroprotective properties for the treatment of Alzheimer's disease.
    Sang Z; Li Y; Qiang X; Xiao G; Liu Q; Tan Z; Deng Y
    Bioorg Med Chem; 2015 Feb; 23(4):668-80. PubMed ID: 25614117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer's disease.
    Cummings JL
    N Engl J Med; 2004 Jul; 351(1):56-67. PubMed ID: 15229308
    [No Abstract]   [Full Text] [Related]  

  • 30. Monoamine oxidase inhibitors as treatment for depressed patients with primary degenerative dementia (Alzheimer's disease).
    Jenike MA
    Am J Psychiatry; 1985 Jun; 142(6):763-4. PubMed ID: 4003602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ongoing trials in Alzheimer's disease.
    Sramek JJ; Cutler NR
    Expert Opin Investig Drugs; 2000 Apr; 9(4):899-915. PubMed ID: 11060718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacotherapy of cognitive impairment in Alzheimer's disease: a review.
    Patel SV
    J Geriatr Psychiatry Neurol; 1995 Apr; 8(2):81-95. PubMed ID: 7794480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Donepezil versus vitamin E in Alzheimer's disease: Part 2: mild versus moderate-severe Alzheimer's disease.
    Onofrj M; Thomas A; Luciano AL; Iacono D; Di Rollo A; D'Andreamatteo G; Di Iorio A
    Clin Neuropharmacol; 2002; 25(4):207-15. PubMed ID: 12151908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perspectives in clinical Alzheimer's disease research and the development of antidementia drugs.
    Grundman M; Corey-Bloom J; Thal LJ
    J Neural Transm Suppl; 1998; 53():255-75. PubMed ID: 9700663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive and neuropsychiatric impairments in Alzheimer's disease: current treatment strategies.
    Borisovskaya A; Pascualy M; Borson S
    Curr Psychiatry Rep; 2014 Sep; 16(9):470. PubMed ID: 25023513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The burden of dementia. A medical and research perspective.
    Antuono P; Beyer J
    Theor Med Bioeth; 1999 Jan; 20(1):3-13. PubMed ID: 10442050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Searching for drugs that combat Alzheimer's.
    Marx J
    Science; 1996 Jul; 273(5271):50-3. PubMed ID: 8658194
    [No Abstract]   [Full Text] [Related]  

  • 38. Drugs for treatment of Alzheimer's disease.
    Wilkinson D
    Int J Clin Pract; 2001 Mar; 55(2):129-34. PubMed ID: 11321852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are cholinesterase inhibitors more than symptomatic treatments for Alzheimer disease?
    Relkin N
    Alzheimer Dis Assoc Disord; 2006; 20(2 Suppl 1):S2. PubMed ID: 16772753
    [No Abstract]   [Full Text] [Related]  

  • 40. Targeting monoamine oxidases with multipotent ligands: an emerging strategy in the search of new drugs against neurodegenerative diseases.
    Pisani L; Catto M; Leonetti F; Nicolotti O; Stefanachi A; Campagna F; Carotti A
    Curr Med Chem; 2011; 18(30):4568-87. PubMed ID: 21864289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.